Literature DB >> 10417312

Differential DNA binding by the androgen and glucocorticoid receptors involves the second Zn-finger and a C-terminal extension of the DNA-binding domains.

E Schoenmakers1, P Alen, G Verrijdt, B Peeters, G Verhoeven, W Rombauts, F Claessens.   

Abstract

The androgen and glucocorticoid hormones evoke specific in vivo responses by activating different sets of responsive genes. Although the consensus sequences of the glucocorticoid and androgen response elements are very similar, this in vivo specificity can in some cases be explained by differences in DNA recognition between both receptors. This has clearly been demonstrated for the androgen response element PB-ARE-2 described in the promoter of the rat probasin gene. Swapping of different fragments between the androgen- and glucocorticoid-receptor DNA-binding domains demonstrates that (i) the first Zn-finger module is not involved in this sequence selectivity and (ii) that residues in the second Zn-finger as well as a C-terminal extension of the DNA-binding domain from the androgen receptor are required. For specific and high-affinity binding to response elements, the DNA-binding domains of the androgen and glucocorticoid receptors need a different C-terminal extension. The glucocorticoid receptor requires 12 C-terminal amino acids for high affinity DNA binding, while the androgen receptor only involves four residues. However, for specific recognition of the PB-ARE-2, the androgen receptor also requires 12 C-terminal residues. Our data demonstrate that the mechanism by which the androgen receptor binds selectively to the PB-ARE-2 is different from that used by the glucocorticoid receptor to bind a consensus response element. We would like to suggest that the androgen receptor recognizes response elements as a direct repeat rather than the classical inverted repeat.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10417312      PMCID: PMC1220386     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  36 in total

1.  Determinants for DNA-binding site recognition by the glucocorticoid receptor.

Authors:  J Zilliacus; A P Wright; U Norinder; J A Gustafsson; J Carlstedt-Duke
Journal:  J Biol Chem       Date:  1992-12-15       Impact factor: 5.157

2.  Participation of non-zinc finger residues in DNA binding by two nuclear orphan receptors.

Authors:  T E Wilson; R E Paulsen; K A Padgett; J Milbrandt
Journal:  Science       Date:  1992-04-03       Impact factor: 47.728

Review 3.  Gene regulation by steroid hormones.

Authors:  M Beato
Journal:  Cell       Date:  1989-02-10       Impact factor: 41.582

4.  Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor.

Authors:  J L Arriza; C Weinberger; G Cerelli; T M Glaser; B L Handelin; D E Housman; R M Evans
Journal:  Science       Date:  1987-07-17       Impact factor: 47.728

5.  Determinants of target gene specificity for steroid/thyroid hormone receptors.

Authors:  K Umesono; R M Evans
Journal:  Cell       Date:  1989-06-30       Impact factor: 41.582

6.  Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors.

Authors:  C S Chang; J Kokontis; S T Liao
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

7.  Genetic complementation of a glucocorticoid receptor deficiency by expression of cloned receptor cDNA.

Authors:  R Miesfeld; S Rusconi; P J Godowski; B A Maler; S Okret; A C Wikström; J A Gustafsson; K R Yamamoto
Journal:  Cell       Date:  1986-08-01       Impact factor: 41.582

8.  The rat androgen receptor: primary structure, autoregulation of its messenger ribonucleic acid, and immunocytochemical localization of the receptor protein.

Authors:  J A Tan; D R Joseph; V E Quarmby; D B Lubahn; M Sar; F S French; E M Wilson
Journal:  Mol Endocrinol       Date:  1988-12

9.  Functional dissection of the hormone and DNA binding activities of the glucocorticoid receptor.

Authors:  S Rusconi; K R Yamamoto
Journal:  EMBO J       Date:  1987-05       Impact factor: 11.598

Review 10.  The steroid and thyroid hormone receptor superfamily.

Authors:  R M Evans
Journal:  Science       Date:  1988-05-13       Impact factor: 47.728

View more
  38 in total

1.  Comparative analysis of the influence of the high-mobility group box 1 protein on DNA binding and transcriptional activation by the androgen, glucocorticoid, progesterone and mineralocorticoid receptors.

Authors:  Guy Verrijdt; Annemie Haelens; Erik Schoenmakers; Wilfried Rombauts; Frank Claessens
Journal:  Biochem J       Date:  2002-01-01       Impact factor: 3.857

2.  DNA recognition by the androgen receptor: evidence for an alternative DNA-dependent dimerization, and an active role of sequences flanking the response element on transactivation.

Authors:  Annemie Haelens; Guy Verrijdt; Leen Callewaert; Valerie Christiaens; Kris Schauwaers; Ben Peeters; Wilfried Rombauts; Frank Claessens
Journal:  Biochem J       Date:  2003-01-01       Impact factor: 3.857

3.  Kaiso uses all three zinc fingers and adjacent sequence motifs for high affinity binding to sequence-specific and methyl-CpG DNA targets.

Authors:  Bethany A Buck-Koehntop; Maria A Martinez-Yamout; H Jane Dyson; Peter E Wright
Journal:  FEBS Lett       Date:  2012-01-30       Impact factor: 4.124

4.  Molecular Basis of Steroid Action in the Prostate.

Authors:  Yuan-Shan Zhu
Journal:  Cellscience       Date:  2005-04-28

5.  Expression of Tubb3, a beta-tubulin isotype, is regulated by androgens in mouse and rat Sertoli cells.

Authors:  Karel De Gendt; Evi Denolet; Ariane Willems; Veerle W Daniels; Liesbeth Clinckemalie; Sarah Denayer; Miles F Wilkinson; Frank Claessens; Johannes V Swinnen; Guido Verhoeven
Journal:  Biol Reprod       Date:  2011-07-06       Impact factor: 4.285

Review 6.  Orphan nuclear receptors in breast cancer pathogenesis and therapeutic response.

Authors:  Rebecca B Riggins; Mary M Mazzotta; Omar Z Maniya; Robert Clarke
Journal:  Endocr Relat Cancer       Date:  2010-08-16       Impact factor: 5.678

Review 7.  New Opportunities for Targeting the Androgen Receptor in Prostate Cancer.

Authors:  Margaret M Centenera; Luke A Selth; Esmaeil Ebrahimie; Lisa M Butler; Wayne D Tilley
Journal:  Cold Spring Harb Perspect Med       Date:  2018-12-03       Impact factor: 6.915

8.  The DNA binding CXC domain of MSL2 is required for faithful targeting the Dosage Compensation Complex to the X chromosome.

Authors:  Torsten Fauth; Felix Müller-Planitz; Cornelia König; Tobias Straub; Peter B Becker
Journal:  Nucleic Acids Res       Date:  2010-02-05       Impact factor: 16.971

9.  Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor.

Authors:  Sha Tian; Hetti Poukka; Jorma J Palvimo; Olli A Jänne
Journal:  Biochem J       Date:  2002-11-01       Impact factor: 3.857

10.  Manipulating prohibitin levels provides evidence for an in vivo role in androgen regulation of prostate tumours.

Authors:  D Alwyn Dart; Bradley Spencer-Dene; Simon C Gamble; Jonathan Waxman; Charlotte L Bevan
Journal:  Endocr Relat Cancer       Date:  2009-07-27       Impact factor: 5.678

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.